Mechanistically, this immunosuppressive function of HLA-G has been partially shown to operate by inhibiting the cellular anti-tumor immune response and tumor cell killing through its interaction with receptors ILT2, ILT4, and KIR2DL4 expressed on cytotoxic T cells and NK cells (47, 49–51). The gene discussed is LILRB1; the disease is neoplasm.